CHEYENNE, Wyo., Jan. 26, 2017 /PRNewswire/ -- The directors and management of N1 Technologies Corp. (OTC PINK:NNSV) announced today that NanoSave Technologies has acquired all rights and titles to the Viritron VDX, Viritron VPN and Viritron Mini Lab patents, representing an overall increase IP valuation. "NanoSave Technologies is a Global leader in Nano Technology research and development and this latest asset acquisition is another development in our desire to create a stand alone Bio Technology division for our company," states CEO Steve Lovern. " N1 Technologies Corp. a Bio Technology research company will trade as NanoSave Technologies OTC: NNSV going forward. This unites all the Nano Technology patents and products under one roof allowing investors to own a part of all our innovations with one stock," Mr. Lovern went on to say. N1 Technologies Corp. the new Bio Tech division has set up its Executive offices in Atlanta Georgia in the fashionable Dunwoody area.
In Other News, NanoSave Technologies is preparing to post its Q4 2016 Financial statements which will reflect the company's acquisition of the Viritron Patents and 4th quarter revenues. The company continues to expand rapidly, corporate accountants have indicated that the forth quarter numbers were clearly positive and may have exceeded initial expectations. "We feel very strongly that our numbers will be a pleasant surprise as we combine the operating accounts of NanoSave and N1 into a consolidated financial statement, with both assets and revenues hitting all time highs. We are looking forward to opening new markets in the bio technology arenas and streamlining all aspects of our operations," says Company CEO Steve Lovern. The company envisages these new Bio Tech Patents and Technologies as an exceptional opportunity for our investors going forward. NanoSave Technologies designs, develops, manufactures and markets a wide range of nano-engineered oil products, lubricants and marine coatings to a global market.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "will" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Corporation's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the Corporation. The forward-looking information contained in this release is made as of the date hereof and the Corporation is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nanosave-technologies-nnsv-acquires-viritron-vdx-patents-300397134.html
SOURCE NanoSave Technologies Inc. NNSV